Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Hexabrix
2. Ioxaglate
3. Ioxaglate Sodium
4. Ioxaglate, Methylglucamine
5. Ioxaglic Acid
6. Ioxaglic Acid Monosodium Salt
7. Ioxaglic Acid, Calcium Salt (2:1)
8. Meglumine, Ioxaglate
9. Methylglucamine Ioxaglate
10. P-286 (contrast Media)
11. P286 (contrast Media)
1. Meglumine Ioxaglate
2. Ioxaglate Meglumine [usan]
3. 59018-13-2
4. Mp 302 (mixt. With Ioxaglate Sodium)
5. Hexabrix
6. 75jr975t11
7. Ioxaglate Meglumine (usan)
8. N-(2-hydroxyethyl)-2,4,6-triiodo-5-(2-(2,4,6-triiodo-3-(n-methylacetamido)-5-(methylcarbamoyl)benzamido)acetamido)isophthalamic Acid, Compound With 1-deoxy-1-(methylamino)-d-glucitol (1:1)
9. 3-[[2-[[3-[acetyl(methyl)amino]-2,4,6-triiodo-5-(methylcarbamoyl)benzoyl]amino]acetyl]amino]-5-(2-hydroxyethylcarbamoyl)-2,4,6-triiodobenzoic Acid;(2r,3r,4r,5s)-6-(methylamino)hexane-1,2,3,4,5-pentol
10. Benzoic Acid, 3-((((3-(acetylmethylamino)-2,4,6-triiodo-5-((methylamino)carbonyl)benzoyl)amino)acetyl)amino)-5-(((2-hydroxyethyl)amino)carbonyl)-2,4,6-triiodo-, Compound With 1-deoxy-1-(methylamino)-d-glucitol (1:1)
11. Ioxagluc Acid
12. Unii-75jr975t11
13. Einecs 261-561-7
14. Mp 302 (mixt.with Iosaglate Sodium)
15. Schembl666706
16. Chembl1200508
17. Ioxaglate Meglumine [vandf]
18. Meglumine Ioxaglate [mart.]
19. Ioxaglate Meglumine [who-dd]
20. Mp-302
21. Ioxaglate Meglumine [orange Book]
22. Hexabrix Component Ioxaglate Meglumine
23. D04598
24. Ioxaglate Meglumine Component Of Hexabrix
25. Q27266396
26. 1-deoxy-1-(methylamino)-d-glucitol 3-((((3-(acetylmethylamino)-2,4,6-triiodo-5-((methylamino)carbonyl)benzoyl)amino)acetyl)amino)-5-(((2-hydroxyethyl)amino)carbonyl)-2,4,6-triiodobenzoate
| Molecular Weight | 1464.1 g/mol |
|---|---|
| Molecular Formula | C31H38I6N6O13 |
| Hydrogen Bond Donor Count | 12 |
| Hydrogen Bond Acceptor Count | 14 |
| Rotatable Bond Count | 16 |
| Exact Mass | 1463.6765 g/mol |
| Monoisotopic Mass | 1463.6765 g/mol |
| Topological Polar Surface Area | 307 Ų |
| Heavy Atom Count | 56 |
| Formal Charge | 0 |
| Complexity | 1220 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 4 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
Contrast Media
Substances used to allow enhanced visualization of tissues. (See all compounds classified as Contrast Media.)
ABOUT THIS PAGE
A Ioxaglate Meglumine manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Ioxaglate Meglumine, including repackagers and relabelers. The FDA regulates Ioxaglate Meglumine manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Ioxaglate Meglumine API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Ioxaglate Meglumine supplier is an individual or a company that provides Ioxaglate Meglumine active pharmaceutical ingredient (API) or Ioxaglate Meglumine finished formulations upon request. The Ioxaglate Meglumine suppliers may include Ioxaglate Meglumine API manufacturers, exporters, distributors and traders.
Ioxaglate Meglumine Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Ioxaglate Meglumine GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Ioxaglate Meglumine GMP manufacturer or Ioxaglate Meglumine GMP API supplier for your needs.
A Ioxaglate Meglumine CoA (Certificate of Analysis) is a formal document that attests to Ioxaglate Meglumine's compliance with Ioxaglate Meglumine specifications and serves as a tool for batch-level quality control.
Ioxaglate Meglumine CoA mostly includes findings from lab analyses of a specific batch. For each Ioxaglate Meglumine CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Ioxaglate Meglumine may be tested according to a variety of international standards, such as European Pharmacopoeia (Ioxaglate Meglumine EP), Ioxaglate Meglumine JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Ioxaglate Meglumine USP).
LOOKING FOR A SUPPLIER?
